X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5937) 5937
Publication (779) 779
Book Review (75) 75
Book Chapter (67) 67
Conference Proceeding (9) 9
Dissertation (8) 8
Patent (8) 8
Book / eBook (4) 4
Magazine Article (3) 3
Streaming Video (3) 3
Paper (2) 2
Web Resource (2) 2
Data Set (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (4231) 4231
humans (4035) 4035
non-alcoholic fatty liver disease (2816) 2816
male (2645) 2645
fatty liver (1995) 1995
animals (1950) 1950
female (1840) 1840
gastroenterology & hepatology (1691) 1691
liver diseases (1624) 1624
insulin-resistance (1463) 1463
liver (1442) 1442
middle aged (1349) 1349
insulin resistance (1330) 1330
obesity (1326) 1326
metabolic syndrome (1299) 1299
liver - pathology (1155) 1155
liver - metabolism (1127) 1127
adult (1123) 1123
risk factors (1113) 1113
steatohepatitis (1059) 1059
mice (1038) 1038
nonalcoholic steatohepatitis (1023) 1023
fibrosis (992) 992
fatty liver-disease (983) 983
hepatic steatosis (965) 965
non-alcoholic fatty liver disease - drug therapy (952) 952
non-alcoholic fatty liver disease - metabolism (934) 934
steatosis (910) 910
inflammation (852) 852
non-alcoholic fatty liver disease - pathology (826) 826
oxidative stress (755) 755
non-alcoholic steatohepatitis (712) 712
nafld (701) 701
prevalence (701) 701
liver - drug effects (676) 676
aged (637) 637
analysis (623) 623
nonalcoholic fatty liver disease (615) 615
diet (606) 606
endocrinology & metabolism (582) 582
non-alcoholic fatty liver disease - complications (578) 578
metabolism (567) 567
disease models, animal (564) 564
gastroenterology and hepatology (561) 561
diabetes (553) 553
mice, inbred c57bl (545) 545
rodents (534) 534
rats (533) 533
disease (523) 523
non-alcoholic fatty liver disease - therapy (505) 505
fatty liver - metabolism (492) 492
non-alcoholic fatty liver disease - diagnosis (487) 487
non-alcoholic fatty liver disease - etiology (483) 483
pharmacology & pharmacy (476) 476
biopsy (475) 475
nutritional and metabolic diseases (474) 474
care and treatment (473) 473
non-alcoholic fatty liver disease - blood (471) 471
digestive system diseases (468) 468
fatty liver - pathology (463) 463
liver cirrhosis (462) 462
article (461) 461
lipids (457) 457
health aspects (456) 456
fatty liver - drug therapy (453) 453
body mass index (447) 447
non-alcoholic fatty liver disease - epidemiology (441) 441
treatment outcome (435) 435
fatty acids (433) 433
nutrition & dietetics (431) 431
hepatology (422) 422
insulin (418) 418
physiological aspects (412) 412
biochemistry & molecular biology (409) 409
hepatocellular-carcinoma (409) 409
cirrhosis (407) 407
obesity - complications (390) 390
glucose (384) 384
research (380) 380
disease progression (379) 379
nash (375) 375
lipid metabolism (373) 373
diagnosis (372) 372
risk-factors (372) 372
cholesterol (371) 371
medicine (368) 368
expression (367) 367
type 2 diabetes (367) 367
biomarkers - blood (365) 365
fatty liver - etiology (361) 361
non-alcoholic fatty liver disease - genetics (356) 356
risk (350) 350
development and progression (349) 349
pathogenesis (345) 345
medicine & public health (343) 343
gene expression (336) 336
hepatitis (330) 330
research article (330) 330
adolescent (329) 329
diet, high-fat - adverse effects (329) 329
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5694) 5694
Chinese (91) 91
Russian (52) 52
German (41) 41
Japanese (37) 37
Spanish (32) 32
Korean (20) 20
French (15) 15
Ukrainian (10) 10
Hungarian (8) 8
Czech (3) 3
Polish (3) 3
Croatian (2) 2
Italian (2) 2
Persian (2) 2
Danish (1) 1
Dutch (1) 1
Icelandic (1) 1
Portuguese (1) 1
Swedish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Royal Society Open Science, ISSN 2054-5703, 11/2018, Volume 5, Issue 11, p. 181457
Resveratrol (3, 40, 5-trihydroxy-trans-stilbene, RSV), a nutraceutical, has recently attracted lots of attention because of its outstanding pharmacological... 
Bioactivity | Stability | Non-alcoholic fatty liver disease | PLGA nanoparticles | Resveratrol | Solubility | non-alcoholic fatty liver disease | DRUG-DELIVERY | MULTIDISCIPLINARY SCIENCES | RELEASE | FORMULATION | CANCER | BIOAVAILABILITY | IN-VITRO | bioactivity | solubility | TRANS-RESVERATROL | DEGRADATION | MICROENCAPSULATION | ORAL DELIVERY | resveratrol | stability
Journal Article
BMC Medicine, ISSN 1741-7015, 02/2017, Volume 15, Issue 1, p. 45
Journal Article
Clinical Gastroenterology and Hepatology, ISSN 1542-3565, 2016, Volume 15, Issue 4, pp. 474 - 485
Journal Article
Journal Article
世界胃肠病学杂志:英文版, ISSN 1007-9327, 2017, Volume 23, Issue 42, pp. 7495 - 7504
Journal Article